Morning Brief

Wake up to the Morning Quant Ride, your global markets update every morning!

Morning Quant Ride Feb 1, 2018

Feb 01, 2018

February 1, 2018

Traders’ Corner

Today we reset our Multi-Factor Quantitative models to reflect market moves this past January (2018). Be on the lookout for our new A-rated and F-Rated stocks by mid-morning!

Asian markets traded mostly higher overnight following gains in the US on Wednesday.  While most focused on the FOMC meeting little from that event impacted share prices on Asia.  European markets were mostly higher midday though often their intraday highs.  Data across the continent was mixed with little in the way of drivers.

US markets closed slightly higher yesterday following two straight days of losses. This morning, our attention will be on our A-rated healthcare stocks; healthcare stocks under-performed the S&P500 yesterday, with the sector closing down 1.45%. Concerns from Tuesday's Amazon/Berkshire/JP Morgan announcement may be overstated.

Yesterday's Fed commentary suggests inflation expectations are for inflation to accelerate this year and reach 2% in the “medium-term”, which is in-line with the Fed's long term target. Fed funds futures, currently, are pricing in three rate hikes this year.

In this environment, where rates are rising concurrently with the potential for expansionary fiscal policy (infrastructure stimulus), investors may want to consider allocations to low beta sectors as high beta sectors significantly outperformed low beta sectors in January 2018. The out-performance was likely a follow-through from the tax reform bill passed in December 2017. Low beta sectors tend to be more defensive than high beta sectors: lower return with lower volatility (and typically higher dividend yields). The current macro environment coupled with the S&P500 5.73% return since the beginning of 2017 does not point to such a dispersion in performance between low beta and high beta sectors. Expect some reversion to the mean over the next few weeks.

S&P 500 January Sector Returns

S&P 500


S&P 500 / Consumer Discretionary -SEC


S&P 500 / Consumer Staples -SEC


S&P 500 / Energy -SEC


S&P 500 / Financials -SEC


S&P 500 / Health Care -SEC


S&P 500 / Industrials -SEC


S&P 500 / Information Technology -SEC


S&P 500 / Materials -SEC


S&P 500 / Real Estate - SEC


S&P 500 / Telecommunications Services -SEC


S&P 500 / Utilities -SEC


Our Top Picks in the News

Click headline for story
A Very Strong Earnings Picture (Zacks)
The Investors’ After-Party (Barron's)
The S&P 500's January to Remember Could Make This a Year to Remember (Barron's)

Alibaba (BABA)

Alibaba reports Q3 adjusted EPS $1.63, consensus $1.67 (TheFly)
See more on our Alibaba QuantShot company report from December 5th 

Boston Scientific Corporation (BSX)

Boston Scientific Sees Q1 adj. EPS 30c-32c, consensus 32c (The Fly)

Facebook (FB)

Facebook (FB) PT Raised to $250 at Susquehanna (Street Insider)
See more on our Facebook QuantShot company report from January 10th 

Cigna (CI)

Cigna Issues Upbeat FY18 Outlook- Quick Facts (RTT News)

MasterCard (MA)

MasterCard selected by Bass Pro Shops and Cabela's for co-brand portfolio (The Fly)

Alphabet (GOOGL)

Google's G Suite is no Microsoft killer, but still winning converts (Reuters)
See more on our Alphabet QuantShot company report from January 11th

The Morning Recap

Global Indices



1 Day Return

5 Day Return



S&P 500

$ 2,823.81





Russell 2000

$ 1,574.98





DJ Industrial Average

$ 26,149.39





NASDAQ Composite Index

$ 7,411.48





CBOE Market Volatility Index






Germany DAX (TR)

€ 13,175.10





France CAC 40

€ 5,493.22





Japan Nikkei 225

¥ 23,486.11





Hang Seng Index

¥ 32,642.09





Hang Seng China Enterprises

¥ 13,434.14





S&P ASX 200

AUD 6,090.10





Source: FactSet          

Line for QuantShots

Quantalytics Research is the trade name of Quantalytics Research, LLC.


Quantalytics Research, LLC is not an investment adviser, brokerage firm, or investment company. Any data, information, or opinions presented by Quantalytics Research are for general information purposes only. Such data, information, or opinions are not an offer to sell or to buy, or a solicitation to buy or sell any securities. All investments and investment recommendations entail risks. Any forward looking estimates presented by Quantalytics Research through Quantalytics Edge may prove to be incorrect and not be realized. Any data, information, or opinions expressed in Quantalytics Research in any form may change without notice. Any data, information, or opinions in Quantalytics Research in any form attributed to a third party represent Quantalytics Research's interpretation of the data, information, or opinions provided by that third party either publicly or through a subscription service, and such use and interpretation have not been reviewed by the third party. The data, information and opinions presented have been obtained or derived from sources believed by Quantalytics Research in any form to be reliable. Quantalytics Research, doesn't make any representations as to their accuracy or completeness. Nothing discussed or presented in Quantalytics Research constitutes a representation that any investment, investment strategy, or recommendation is suitable or appropriate to an investor's individual circumstances or otherwise constitutes a personal recommendation. Data, information, or opinions contained in Quantalytics Research in any form give no consideration to any particular individuals' investment needs or objectives, nor do they consider any individuals' financial condition. Consequently, any such data, information, or opinions do not in any way represent a personal recommendation to any individual investor or any entities, whatever the type. Quantalytics Research does not accept any liability for any losses or damages arising from the use of the data, information, or opinions included in Quantalytics Research in any form. All investments involve risks of loss and potential permanent impairment of capital. Investors should diversify risks and exercise prudence and their own judgement in making their investment decisions. Quantalytics Research and any information contained therein is not intended for distribution to or use by any person, or entity, who is a citizen or resident of or located in any locality, state, country, or jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or cause Quantalytics Research, LLC to be required to register or be licensed within any such venues. All data, information, and opinions expressed in Quantalytics Research in any form are as of the date of publication and are subject to change. Quantalytics Research partners and employees may own or have positions in any investment(s) mentioned respectively therein or related thereto and may, from time to time add to, or dispose of, any such investment(s).